Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer

被引:7
|
作者
Quan, ML
Fey, J
Eitan, R
Abu-Rustum, NR
Barakat, RR
Borgen, PI
Gemignani, ML
机构
[1] Mem Sloan Kettering Canc Ctr, Acad Off, Gynecol Serv, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Breast Serv, Dept Surg, New York, NY 10021 USA
关键词
laparoscopy; adnexa; breast cancer;
D O I
10.1016/j.ygyno.2003.10.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To describe the utility of laparoscopic evaluation of adnexal masses in women with stage IV breast cancer. Methods. A retrospective review of gynecologic and breast surgery databases at our institution was performed to identify patients with stage IV breast cancer who underwent surgical evaluation for an adnexal mass or bilateral salpingo-oophorectomy (BSO) between January 1986 and August 2002. Patient demographics and operative and pathologic findings were reviewed. Results. Thirty-one patients Were identified. Median age was 47 years (range, 25-79 years). Pathology of the primary breast tumor was infiltrating ductal carcinoma in 58%, invasive lobular carcinoma in 29%, and unspecified in 13%. Median time from diagnosis of stage IV breast cancer to surgical evaluation of the adnexa was 15 months (range, 0-106 months). Surgery consisted of planned laparotomy in four patients and laparoscopic evaluation in 27 patients. Six patients had laparoscopic BSO for hormonal ablation. The remaining 21 patients had laparoscopic evaluation of an adnexal mass. Conversion to laparotomy occurred in three patients based on intraoperative findings of suspected primary ovarian cancer and for technical reasons in one patient. Overall, metastatic breast cancer was diagnosed in 21 (68%) of 31 patients, including two patients with occult metastases undergoing BSO for hormonal ablation. Primary ovarian cancer was found in 3 (10%) of 31 patients, and 7 (22%) of 31 patients had benign findings. Pathologic intraoperative frozen section was obtained in 21 (84%) of 25 patients undergoing laparoscopic evaluation for an adnexal mass. Intraoperative frozen section was concordant with final pathology in 20 (95%) of 21 patients (18 on laparoscopic evaluation, two on laparotomy). Conclusions. The majority of patients with stage IV breast cancer who present with an adnexal mass will be diagnosed with metastatic breast cancer. A small subset of patients will be diagnosed with primary ovarian cancer; thus, the evaluation of an adnexal mass even in this stage IV setting is warranted. Accurate diagnosis of metastatic breast cancer versus ovarian cancer can be made laparoscopically, thereby avoiding laparotomy in the metastatic breast cancer setting. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 50 条
  • [21] The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer
    Tokunaga, Eriko
    Koi, Yumiko
    Tajiri, Wakako
    Koga, Chinami
    Ijichi, Hideki
    Akiyoshi, Sayuri
    Kawasaki, Junji
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Okamoto, Masahiro
    BREAST CANCER, 2025, 32 (02) : 426 - 433
  • [22] LAPAROSCOPY TO CORRECTLY DIAGNOSE AND STAGE METASTATIC BREAST-CANCER MIMICKING CROHNS-DISEASE
    EASTER, DW
    JAMSHIDIPOUR, R
    MCQUAID, K
    SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 1995, 9 (07): : 820 - 823
  • [23] Resection of the primary tumor in stage IV breast cancer
    Shien, Tadahiko
    Doihara, Hiroyoshi
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (02): : 82 - 85
  • [24] Will breast surgery be a useful option for treatment of stage IV breast cancer?
    Wysocki, Wojciech M.
    Burzynski, Tomasz
    Komorowski, Andrzej L.
    Mitus, Jerzy
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (06): : 376 - 384
  • [25] Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
    Juan, O
    Lluch, A
    de Paz, L
    Prósper, F
    Azagra, P
    Marugán, I
    Martínez-Agulló, A
    Garcia-Conde, J
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (02) : 105 - 112
  • [26] Survival of de novo stage IV breast cancer patients over three decades
    Hoelzel, Dieter
    Eckel, Renate
    Bauerfeind, Ingo
    Baier, Bernd
    Beck, Thomas
    Braun, Michael
    Ettl, Johannes
    Hamann, Ulrich
    Harbeck, Nadia
    Kiechle, Marion
    Mahner, Sven
    Schindlbeck, Christian
    de Waal, Johann
    Engel, Jutta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (03) : 509 - 519
  • [27] Survival of de novo stage IV breast cancer patients over three decades
    Dieter Hölzel
    Renate Eckel
    Ingo Bauerfeind
    Bernd Baier
    Thomas Beck
    Michael Braun
    Johannes Ettl
    Ulrich Hamann
    Nadia Harbeck
    Marion Kiechle
    Sven Mahner
    Christian Schindlbeck
    Johann de Waal
    Jutta Engel
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 509 - 519
  • [28] Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
    Oscar Juan
    Ana Lluch
    Laura de Paz
    Felipe Prósper
    Pilar Azagra
    Isabel Marugán
    Angel Martínez-agulló
    Javier Garcia-conde
    Breast Cancer Research and Treatment, 1999, 53 : 105 - 112
  • [29] Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
    Li, Shunrong
    Zhao, Jianli
    Zhu, Liling
    Su, Fengxi
    Chen, Kai
    CANCER MEDICINE, 2017, 6 (11): : 2586 - 2594
  • [30] The Efficacy of Inflammatory and Immune Markers for Predicting the Prognosis of Patients with Stage IV Breast Cancer
    Yamanouchi, Kosho
    Maeda, Shigeto
    ACTA MEDICA OKAYAMA, 2023, 77 (01) : 37 - 43